Fuse Science, Inc. Share Price

Equities

DROP

US36113J3041

Aerospace & Defense

Market Closed - OTC Markets 09:05:07 21/05/2024 pm IST 5-day change 1st Jan Change
0.012 USD -4.00% Intraday chart for Fuse Science, Inc. 0.00% +27.66%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Take advantage of the offer
* See conditions on site
Sales 2014 449K 37.34M Sales 2015 - Capitalization 176K 14.65M
Net income 2014 -7M -583M Net income 2015 -24M -2B EV / Sales 2014 2.12 x
Net Debt 2014 19.8K 1.65M Net cash position 2015 99.08K 8.25M EV / Sales 2015 -
P/E ratio 2014
-0.12 x
P/E ratio 2015
-0.01 x
Employees 1
Yield 2014 *
-
Yield 2015
-
Free-Float 31.68%
More Fundamentals * Assessed data
Dynamic Chart
Fuse Science, Inc. Announces Executive Changes CI
David Rector Resigns as Member of Board of Directors of Fuse Science, Inc. and from His Positions as CEO, CFO and All Other Officer Positions CI
Exactus BioSolutions, Inc. acquired Spiral Energy Tech., Inc. in a reverse merger transaction. CI
Fuse Science, Inc. Announces Management Changes CI
Gelvin Stevenson Resigns as a Member of Board of Directors of Fuse Science, Inc CI
Fuse Science, Inc. Auditor Raises 'Going Concern' Doubt CI
Fuse Science, Inc. (OTCPK:DROP.D) acquired 51% stake in Spiral Energy Tech., Inc. for $49.5 million. CI
Fuse Science, Inc. announced that it has received $0.02 million in funding. CI
Fuse Science, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2013 CI
Fuse Science, Inc. Reports Earnings Results for the Year Ended September 30, 2013 CI
Fuse Science, Inc. Auditor Raises 'Going Concern' Doubt CI
Fuse Science, Inc. announced that it expects to receive $1 million in funding from GRQ Consultants, Inc. 401K Plan and Hudson Bay Capital Management LP. CI
Fuse Science, Inc. Announces Demise of its Member of Board and Chairperson of the Compensation Committee, James T. Frederick CI
Fuse Science, Inc. Updates on the Introduction of Macular's Health's New MacuDrop AREDS II Formula Containing Fuse Science(R) Technology CI
Fuse Science, Inc. announced that it has received $0.70 million in funding from Melechdavid, Inc., Muscle Pharm Corp., Frost Gamma Investments Trust, and other investors. CI
More news
1 day-4.00%
Current month-17.24%
1 month+0.84%
3 months+20.00%
6 months+100.00%
Current year+27.66%
More quotes
1 week
0.01
Extreme 0.01
0.02
1 month
0.01
Extreme 0.01
0.02
Current year
0.01
Extreme 0.007
0.02
1 year
0.00
Extreme 0.0031
0.02
3 years
0.00
Extreme 0.0031
0.07
5 years
0.00
Extreme 0
0.09
10 years
0.00
Extreme 0
16.80
More quotes
Managers TitleAgeSince
Chief Executive Officer - -
More insiders
Date Price Change Volume
21/24/21 0.012 -4.00% 180,000
20/24/20 0.0125 +5.93% 80,338
17/24/17 0.0118 -23.87% 47,400
16/24/16 0.0155 +21.09% 140,945
15/24/15 0.0128 +7.11% 100,075

Delayed Quote OTC Markets, May 21, 2024 at 09:05 pm IST

More quotes
Fuse Science, Inc. is engaged in developing and commercializing its SkyPorts drone support technology and Energy Demand Network (EDEN). This technology enables the long distance flight required for drone-based commerce without the need for drones to return home every 15 minutes to recharge. The technology allows a drone operator to travel many miles outside of its home range allowing for a flight path of numerous miles limited only by its EDEN network of SkyPorts. The Company is also involved in developing and commercializing XTRAX remote monitoring systems. The range of applications include from agricultural inspections and monitoring to pharmacy and fast food deliveries. The Company has not generated any revenue.
More about the company
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW